Showing results (551-560 of 1,983) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|September 8, 2019
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trialGiancarlo Comi, Ludwig Kappos, Krzysztof W Selmaj, et al.
The Lancet. Neurology|April 19, 2008
Endpoints for trials in Alzheimer's disease: a European task force consensusBruno Vellas, Sandrine Andrieu, Cristina Sampaio, et al.
The Lancet. Neurology|April 19, 2008
Management of neurogenic orthostatic hypotension: an updatePhillip A Low, Wolfgang Singer
The Lancet. Neurology|April 19, 2008
Metastatic epidural spinal cord compressionJohn S Cole, Roy A Patchell
The Lancet. Neurology|April 25, 2017
Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort studyJosé M A Wijnands, Elaine Kingwell, Feng Zhu, et al.
The Lancet. Neurology|August 19, 2011
Neuroschistosomiasis: clinical symptoms and pathogenesisTeresa Cristina A Ferrari, Paulo Roberto R Moreira
The Lancet. Neurology|December 14, 2011
A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification studyIlse Gijselinck, Tim Van Langenhove, Julie van der Zee, et al.
The Lancet. Neurology|October 1, 2011
Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudyLenore J Launer, Michael E Miller, Jeff D Williamson, et al.
The Lancet. Neurology|April 21, 2012
Childhood spinal muscular atrophy: controversies and challengesEugenio Mercuri, Enrico Bertini, Susan T Iannaccone
The Lancet. Neurology|December 17, 2011
Migraine and stroke: a complex association with clinical implicationsTobias Kurth, Hugues Chabriat, Marie-Germaine Bousser
Pageof 199